Cromolyn Sodium (Wallace Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cromolyn Sodium drug offered from Wallace Pharmaceuticals Inc.. This Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wallace Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | cromolyn sodium |
| SUBSTANCE NAME: | CROMOLYN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Mast Cell Stabilizer [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-06-15 |
| END MARKETING DATE: | 2018-05-31 |
Cromolyn Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cromolyn Sodium from Wallace Pharmaceuticals Inc. |
| LABELER NAME: | Wallace Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2015-06-15 |
| END MARKETING DATE: | 2018-05-31 |
| PRODUCT ID: | 51525-470_f4eb8dee-b5db-40f6-8857-19b4ca7f6d9c |
| PRODUCT NDC: | 51525-470 |
| APPLICATION NUMBER: | NDA020479 |
Other CROMOLYN SODIUM Pharmaceutical Manufacturers / Labelers:
